Expertise in
13
conditions

Kerstin A. Klotz

Bonn, NW, DE 
Expertise in
13
conditions
Bonn, NW, DE 

Overview

Kerstin Klotz practices practicing medicine in Bonn, Germany.

Ms. Klotz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Hypothalamic Hamartomas, Epilepsy, Myoclonic Epilepsy, and Lennox-Gastaut Syndrome (LGS).

She is actively involved in clinical research, co-authoring 53 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Bonn, NW, Germany
Other Locations
Freiburg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
View 1 Less Clinical Trial

53 Total Publications

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.
Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.
Journal: Epilepsia
Published: March 13, 2026

Frequently Asked Questions about Kerstin A. Klotz

Is Kerstin A. Klotz a top-rated expert for Hypothalamic Hamartomas?

MediFind is an objective health platform that identifies experts based on real-world data. Kerstin A. Klotz is classified as an Distinguished expert for Hypothalamic Hamartomas, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kerstin A. Klotz participate in research or clinical trials?

Yes. Kerstin A. Klotz has published 53 articles and abstracts on conditions like Hypothalamic Hamartomas. You can view a list of Kerstin A. Klotz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Klotz's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile